Faricimab demonstrated noninferior vision gains and improved anatomical outcomes among patients with diabetic macular edema ...
The FDA has expanded the labeling for Izervay (avacincaptad pegol) to include longer-term administration for geographic ...
The Sing IMT improved distance and near vision at 6 months in patients with late-stage age-related macular degeneration, with ...
Martin Friedlander, MD, PhD, discusses phase 3 macular telangiectasia findings, highlighting the potential for a decade-long ...
In the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.
Susvimo is also approved to treat age-related macular degeneration, and the medication, ranibizumab, is delivered though a ...
Macular degeneration is a leading cause of vision loss for people over 50, but there are ways to help protect your eyesight.
Designed for people experiencing macular degeneration—the leading cause of vision loss among people over the age of 60—the glasses mimic insect eyes, which use anywhere from dozens to ...
Retinitis pigmentosa is a relatively rare genetic disorder (affecting 1 in 3,500 people), while age-related macular degeneration affects 7–8% of the population, and its incidence increases with age.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback